PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20373475-3 2010 We evaluated prolactin levels in schizophrenic patients receiving risperidone (3 mg twice daily), olanzapine (10 mg twice daily), or perospirone (16 mg twice daily) for at least 4 weeks. Olanzapine 98-108 prolactin Homo sapiens 13-22 20170699-0 2010 Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia. Olanzapine 84-94 prolactin Homo sapiens 16-25 20170699-2 2010 Recent studies have suggested that the prolactin response to olanzapine is weaker than that to risperidone. Olanzapine 61-71 prolactin Homo sapiens 39-48 20170699-7 2010 Treatment with either risperidone or olanzapine boosted plasma prolactin levels above baseline in both males and females. Olanzapine 37-47 prolactin Homo sapiens 63-72 20170699-10 2010 Delta prolactin (prolactin level at four weeks minus the baseline prolactin level) during olanzapine treatment significantly correlated with olanzapine concentration at 4th week (r=-0.518, p<0.01) only in males. Olanzapine 90-100 prolactin Homo sapiens 6-15 20170699-10 2010 Delta prolactin (prolactin level at four weeks minus the baseline prolactin level) during olanzapine treatment significantly correlated with olanzapine concentration at 4th week (r=-0.518, p<0.01) only in males. Olanzapine 90-100 prolactin Homo sapiens 17-26 20170699-10 2010 Delta prolactin (prolactin level at four weeks minus the baseline prolactin level) during olanzapine treatment significantly correlated with olanzapine concentration at 4th week (r=-0.518, p<0.01) only in males. Olanzapine 90-100 prolactin Homo sapiens 17-26 20170699-10 2010 Delta prolactin (prolactin level at four weeks minus the baseline prolactin level) during olanzapine treatment significantly correlated with olanzapine concentration at 4th week (r=-0.518, p<0.01) only in males. Olanzapine 141-151 prolactin Homo sapiens 6-15 20170699-10 2010 Delta prolactin (prolactin level at four weeks minus the baseline prolactin level) during olanzapine treatment significantly correlated with olanzapine concentration at 4th week (r=-0.518, p<0.01) only in males. Olanzapine 141-151 prolactin Homo sapiens 17-26 20170699-10 2010 Delta prolactin (prolactin level at four weeks minus the baseline prolactin level) during olanzapine treatment significantly correlated with olanzapine concentration at 4th week (r=-0.518, p<0.01) only in males. Olanzapine 141-151 prolactin Homo sapiens 17-26 20170699-11 2010 Multiple regression analyses showed that delta prolactin during risperidone was significantly correlated with gender (p<0.001) and age (p<0.05) and that delta prolactin during olanzapine significantly correlated with gender (p<0.001) and drug concentration (p<0.01). Olanzapine 182-192 prolactin Homo sapiens 165-174 19333405-0 2009 Prolactin levels in olanzapine treatment correlate with positive symptoms of schizophrenia: results from an open-label, flexible-dose study. Olanzapine 20-30 prolactin Homo sapiens 0-9 19706318-1 2009 This study investigated prolactin levels in two groups of children and adolescents receiving risperidone (N=29) or olanzapine (N=13). Olanzapine 115-125 prolactin Homo sapiens 24-33 19706318-6 2009 On olanzapine treatment, adjusted mean prolactin levels at the 3rd and 6th months of treatment were significantly higher than at the 1st month; at the 12th month it was lower than at the 1st month, but the difference was not significant. Olanzapine 3-13 prolactin Homo sapiens 39-48 19440083-0 2009 Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration. Olanzapine 0-10 prolactin Homo sapiens 166-175 19440083-8 2009 Prolactin concentration was correlated with olanzapine concentration (r = 0.46, P < 0.001). Olanzapine 44-54 prolactin Homo sapiens 0-9 19896213-0 2010 Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients. Olanzapine 46-56 prolactin Homo sapiens 24-33 19896213-1 2010 In patients from two clinical trials, we investigated the associations of single nucleotide polymorphisms (SNPs) in candidate genes with prolactin level changes during treatment with olanzapine/fluoxetine combination. Olanzapine 183-193 prolactin Homo sapiens 137-146 19702492-2 2009 METHOD: Data on prolactin levels were available for haloperidol, pimozide, risperidone, olanzapine, clozapine, ziprasidone, and quetiapine. Olanzapine 88-98 prolactin Homo sapiens 16-25 19131173-0 2009 Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men. Olanzapine 0-10 prolactin Homo sapiens 81-90 19131173-3 2009 This study evaluated the effects of short-term treatment with olanzapine on 12h plasma prolactin and cortisol concentrations in healthy men. Olanzapine 62-72 prolactin Homo sapiens 87-96 19131173-12 2009 In conclusion olanzapine OST and ODT equally elevated the prolactin concentration and significantly shifted its acrophase, thus dissociating PRL and cortisol, while both formulations induced similar insulin resistance as evidenced by the elevated HOMA-IR. Olanzapine 14-24 prolactin Homo sapiens 58-67 19333405-1 2009 OBJECTIVE: This study was designed to investigate the relationship between the treatment effect of olanzapine and the serum prolactin level in schizophrenia and to investigate the factors that may act as predictors of response for olanzapine treatment. Olanzapine 99-109 prolactin Homo sapiens 124-133 19333405-8 2009 RESULTS: In general, the serum prolactin level was decreased in schizophrenia patients with olanzapine treatment, although the difference is not statistically significant (p = .974, p = .246, and p = .363 for the first, second, and third months, respectively). Olanzapine 92-102 prolactin Homo sapiens 31-40 19333405-9 2009 There was a close relationship between the improvement in positive symptoms and the change in serum prolactin levels before and after olanzapine treatment (p = .002). Olanzapine 134-144 prolactin Homo sapiens 100-109 19011427-10 2008 Prolactin increased in the olanzapine group and decreased in the aripiprazole group with a significant between-group difference (P < 0.001). Olanzapine 27-37 prolactin Homo sapiens 0-9 18063941-8 2007 Olanzapine led to a transient mild prolactin elevation. Olanzapine 0-10 prolactin Homo sapiens 35-44 17898346-10 2007 Patients treated with olanzapine, however, had significantly greater weight gain and increases in the levels of hepatic enzymes, prolactin, fasting glucose, fasting total cholesterol, and uric acid. Olanzapine 22-32 prolactin Homo sapiens 129-138 16824658-0 2006 Gender differences in prolactin elevation induced by olanzapine in Japanese drug-naive schizophrenic patients. Olanzapine 53-63 prolactin Homo sapiens 22-31 17126974-6 2007 The marked and moderate increase in plasma PRL levels were found in patients treated with fluphenazine and olanzapine, respectively. Olanzapine 107-117 prolactin Homo sapiens 43-46 16824658-5 2006 Two-way ANOVA showed a significant difference in olanzapine-induced prolactin changes between male and female patients (P = 0.037). Olanzapine 49-59 prolactin Homo sapiens 68-77 16824658-8 2006 Our results indicate the possibility of gender differences in prolactin elevation induced by olanzapine in Japanese drug-naive schizophrenic patients. Olanzapine 93-103 prolactin Homo sapiens 62-71 15650492-6 2004 RESULTS: End-point prolactin levels were significantly higher with risperidone, compared to olanzapine (p = 0.027) or quetiapine (p = 0.008). Olanzapine 92-102 prolactin Homo sapiens 19-28 16768639-8 2006 The mean prolactin level among all patients on risperidone was significantly greater than controls, as well as for those on quetiapine or olanzapine. Olanzapine 138-148 prolactin Homo sapiens 9-18 16488084-4 2006 Baseline prolactin levels in female patients randomized to receive olanzapine (n=14) were 66.3+/-38.7 ng/ml and were 82.0+/-37.6 (p=.32) in those remaining on their pre-study antipsychotic medication (n=14). Olanzapine 67-77 prolactin Homo sapiens 9-18 16488084-6 2006 At study end, patients switched to olanzapine experienced significant reductions in mean serum prolactin levels of 19.8+/-18.1 ng/ml in males (p=.02), and 32.3+/-47.5 ng/ml in females (p=.01), but prolactin continued to be elevated in patients who remained on pre-study antipsychotic treatment. Olanzapine 35-45 prolactin Homo sapiens 95-104 16488084-6 2006 At study end, patients switched to olanzapine experienced significant reductions in mean serum prolactin levels of 19.8+/-18.1 ng/ml in males (p=.02), and 32.3+/-47.5 ng/ml in females (p=.01), but prolactin continued to be elevated in patients who remained on pre-study antipsychotic treatment. Olanzapine 35-45 prolactin Homo sapiens 197-206 16488084-11 2006 Olanzapine treatment may offer sustained reduction in serum prolactin and improvement in sexual and reproductive comorbid symptoms in patients with schizophrenia who have treatment-emergent hyperprolactinemia. Olanzapine 0-10 prolactin Homo sapiens 60-69 16675366-9 2006 Olanzapine, quetiapine and ziprazadone are antipsychotic medicines with a lower likelihood of elevating prolactin. Olanzapine 0-10 prolactin Homo sapiens 104-113 16526181-0 2005 [Prolactin secretion disturbances in schizophrenic patients treated with 2nd generation antipsychotics--risperidone and olanzapine]. Olanzapine 120-130 prolactin Homo sapiens 1-10 15960571-1 2005 OBJECTIVE: The aim of this cross-sectional study was to investigate the degree and frequency of prolactin (PRL) elevation and related symptoms in patients treated with 3 different atypical antipsychotics: clozapine, olanzapine, and risperidone. Olanzapine 216-226 prolactin Homo sapiens 96-105 15960571-5 2005 RESULTS: Elevated PRL levels were found in 16 (89%) of the patients receiving risperidone and in 7 (24%) of the patients receiving olanzapine, but in none of the patients receiving clozapine. Olanzapine 131-141 prolactin Homo sapiens 18-21 15960571-6 2005 In addition, there was a significant difference in median PRL level among the treatment groups (p < .0001), in that the PRL level was higher both in the patients treated with risperidone and in the patients treated with olanzapine, compared to those treated with clozapine. Olanzapine 223-233 prolactin Homo sapiens 58-61 15960571-6 2005 In addition, there was a significant difference in median PRL level among the treatment groups (p < .0001), in that the PRL level was higher both in the patients treated with risperidone and in the patients treated with olanzapine, compared to those treated with clozapine. Olanzapine 223-233 prolactin Homo sapiens 123-126 15960571-8 2005 CONCLUSION: Treatment with risperidone was frequently associated with hyperprolactinemia and related symptoms, whereas the occurrence of PRL elevation and related symptoms was modest in patients receiving olanzapine and nonexistent in those receiving clozapine. Olanzapine 205-215 prolactin Homo sapiens 137-140 15671135-0 2005 Successful treatment of refractory schizophrenia with combined olanzapine and quetiapine in a patient with a prolactin secreting pituitary microadenoma. Olanzapine 63-73 prolactin Homo sapiens 109-118 15677431-2 2004 Our findings indicate that sexual function improved with euprolactinemia in patients switched from treatment with prolactin-elevating antipsychotics to olanzapine. Olanzapine 152-162 prolactin Homo sapiens 59-68 15286066-5 2004 RESULTS: Prolactin levels increased across medication groups reflecting increasingly tight D(2) receptor binding (clozapine, olanzapine, typical antipsychotics and risperidone). Olanzapine 125-135 prolactin Homo sapiens 9-18 13130349-0 2003 [Prolactin Levels and Symptoms of Hyperprolactinemia in Patients Treated with Amisulpride, Risperidone, Olanzapine and Quetiapine] Elevations in prolactin plasma concentration occur with antipsychotics due to their dopamine D2 receptor antagonism. Olanzapine 104-114 prolactin Homo sapiens 1-10 15554747-11 2004 Other atypical antipsychotics, namely olanzapine and ziprasidone, have been reported to be prolactin sparing in adults, but may not be completely devoid of hyperprolactinaemic effects in children and adolescents. Olanzapine 38-48 prolactin Homo sapiens 91-100 14744169-0 2004 Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. Olanzapine 96-106 prolactin Homo sapiens 0-9 14744169-10 2004 Clozapine and olanzapine were associated with decreases of prolactin, whereas haloperidol led to a minor, nonsignificant increase. Olanzapine 14-24 prolactin Homo sapiens 59-68 12890303-8 2003 Substituting risperidone with another antipsychotic (either olanzapine or quetiapine) also led to abatement of the delusions and lowering of prolactin. Olanzapine 60-70 prolactin Homo sapiens 141-150 14658967-1 2003 BACKGROUND: This study evaluates whether high-dose olanzapine is associated with elevation of serum prolactin levels. Olanzapine 51-61 prolactin Homo sapiens 100-109 14658967-2 2003 METHOD: Twenty-four patients taking daily doses of olanzapine of 20, 25, 30, and 40 mg for DSM-IV schizophrenia or schizoaffective disorder had serum prolactin levels measured. Olanzapine 51-61 prolactin Homo sapiens 150-159 14658967-10 2003 Thus, preliminary evidence suggests that using higher doses of olanzapine is generally safe with regard to prolactin levels. Olanzapine 63-73 prolactin Homo sapiens 107-116 12650682-6 2003 RESULTS: Factors that influenced the risk of hyperprolactinemia included gender, with females appearing to be more sensitive than males, and drug treatment, with risperidone and conventional antipsychotic agents increasing prolactin more than olanzapine. Olanzapine 243-253 prolactin Homo sapiens 50-59 13130349-5 2003 Under treatment with quetiapine and olanzapine just temporary elevated prolactin levels were registered. Olanzapine 36-46 prolactin Homo sapiens 71-80 14509051-6 2003 Under treatment with quetiapine and olanzapine just temporary elevated prolactin levels were registered. Olanzapine 36-46 prolactin Homo sapiens 71-80 12467944-8 2002 The olanzapine-treated patients showed a significantly lower maximal DFEN-evoked PRL response and a significantly lower group x time overall PRL release compared with the untreated patient group. Olanzapine 4-14 prolactin Homo sapiens 81-84 12467944-8 2002 The olanzapine-treated patients showed a significantly lower maximal DFEN-evoked PRL response and a significantly lower group x time overall PRL release compared with the untreated patient group. Olanzapine 4-14 prolactin Homo sapiens 141-144 12019665-0 2002 Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. Olanzapine 11-21 prolactin Homo sapiens 25-34 12188977-0 2002 Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine. Olanzapine 134-144 prolactin Homo sapiens 33-42 12188977-4 2002 Correlations between antipsychotic plasma concentration and serum prolactin concentration were significant only for the olanzapine treatment group (r = 0.80, p = 0.002). Olanzapine 120-130 prolactin Homo sapiens 66-75 12084414-0 2002 Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine. Olanzapine 153-163 prolactin Homo sapiens 0-9 12084414-8 2002 The prolactin responses to haloperidol were not altered after treatment with clozapine, but were significantly reduced after the olanzapine treatment. Olanzapine 129-139 prolactin Homo sapiens 4-13 12084414-9 2002 The baseline prolactin levels were not influenced by clozapine treatment, and were moderately but significantly increased after treatment with olanzapine. Olanzapine 143-153 prolactin Homo sapiens 13-22 12019665-6 2002 RESULTS: Serum prolactin levels decreased significantly (p < .01) following the switch from risperidone to olanzapine. Olanzapine 110-120 prolactin Homo sapiens 15-24 11048906-0 2000 The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Olanzapine 15-25 prolactin Homo sapiens 66-75 11704898-13 2001 Moderate increases of prolactin levels were detected during administration of olanzapine. Olanzapine 78-88 prolactin Homo sapiens 22-31 11561066-1 2001 Atypical antipsychotic drugs, which are distinguished from typical antipsychotic drugs by a lower incidence of extra-pyramidal side effects and less propensity to elevate serum prolactin levels (e.g., clozapine, olanzapine, risperidone, quetiapine, ziprasidone), have become the most widely used treatments for schizophrenia, although their precise mechanism of action remains controversial. Olanzapine 212-222 prolactin Homo sapiens 177-186 11403983-0 2001 Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients. Olanzapine 11-21 prolactin Homo sapiens 47-56 11403983-2 2001 The aim of this study was to compare the effects of olanzapine and haloperidol on PRL secretion in male schizophrenic patients. Olanzapine 52-62 prolactin Homo sapiens 82-85 11403983-7 2001 At the end of the 6th week, the PRL values observed with olanzapine treatment were significantly less than those observed with haloperidol, but not different from those of the controls. Olanzapine 57-67 prolactin Homo sapiens 32-35 11403983-9 2001 Our data indicate that short-term olanzapine treatment at doses of 10 mg/day PO causes minimal elevations in PRL secretion in male schizophrenic patients in contrast to haloperidol. Olanzapine 34-44 prolactin Homo sapiens 109-112 11048906-5 2000 RESULTS: PRL elevations were significantly greater with risperidone than with either olanzapine or haloperidol in study 2. and significantly greater than with olanzapine in study 3 (all, P < 0.001). Olanzapine 85-95 prolactin Homo sapiens 9-12 11048906-6 2000 PRL elevations were significantly greater with haloperidol than with olanzapine in study 1 (P < 0.001 ). Olanzapine 69-79 prolactin Homo sapiens 0-3 11048906-10 2000 PRL decreased significantly when treatment was switched from haloperidol to olanzapine. Olanzapine 76-86 prolactin Homo sapiens 0-3 11048906-11 2000 CONCLUSIONS: This side-by-side analysis of 3 independent studies suggests that with the 3 antipsychotic drugs studied, PRL is elevated moderately by olanzapine (mean change, 1-4 ng/mL), intermediately by haloperidol (mean change, approximately 17 ng/mL), and strongly by risperidone (mean change, 45-80 ng/mL). Olanzapine 149-159 prolactin Homo sapiens 119-122 11772702-4 2002 RESULTS: The baseline prolactin levels in patients receiving risperidone (mean=27 ng/ml, SD=14) were abnormally high, but baseline prolactin levels in patients receiving olanzapine (mean=9 ng/ml, SD=5) and clozapine (mean=9 ng/ml, SD=5) were not high. Olanzapine 170-180 prolactin Homo sapiens 131-140 11048906-2 2000 OBJECTIVE: This paper examines the comparative effects on PRL of olanzapine, risperidone, and haloperidol based on data from 3 multicenter, double-blind, randomized clinical trials. Olanzapine 65-75 prolactin Homo sapiens 58-61 10688158-8 1999 In the olanzapine group, PRL levels were correlated with [123I]IBZM binding ratio (r = -0.551; P < 0.01). Olanzapine 7-17 prolactin Homo sapiens 25-28 10688158-10 1999 The lower incidence of prolactin elevation with olanzapine, compared to risperidone, may not be attributed to a lower D2 receptor occupancy. Olanzapine 48-58 prolactin Homo sapiens 23-32 9265916-4 1997 Olanzapine has a favorable acute and tardive extrapyramidal symptom profile relative to haloperidol and caused substantially less elevation of serum prolactin. Olanzapine 0-10 prolactin Homo sapiens 149-158 9989565-2 1999 The new antipsychotics clozapine, risperidone, and olanzapine obtain antipsychotic response with few extrapyramidal side effects and little prolactin elevation. Olanzapine 51-61 prolactin Homo sapiens 140-149 10630453-5 1999 Prolactin was increased above the upper limit of normal for 100% of 10 patients on haloperidol, 70% of 10 patients on olanzapine, and 0% of 15 patients on clozapine (chi2 analyses: H > C, p = 0.004; O > C, p = 0.001). Olanzapine 118-128 prolactin Homo sapiens 0-9 10630453-6 1999 Given the potential endocrine and possible cardiac correlates of hyperprolactinemia, these more robust prolactin elevations in pediatric patients after short-term exposure to olanzapine than those reported for adults justify longer observation intervals with bigger samples to establish treatment safety of atypical antipsychotics in adolescents. Olanzapine 175-185 prolactin Homo sapiens 70-79 9169300-8 1997 Although olanzapine was associated with some increase in prolactin concentrations, increases were transient, occurred less often, and were of lesser magnitude than those observed with haloperidol. Olanzapine 9-19 prolactin Homo sapiens 57-66 33278020-3 2021 The aim of the study was to evaluate if aripiprazole and olanzapine alter prolactin levels, lipid and glucose metabolism and hepatic, haematological, thyroid and renal function. Olanzapine 57-67 prolactin Homo sapiens 74-83 34658963-9 2021 In addition, when risperidone, amisulpride, and olanzapine were the primary AP medications, adjunctive paeoniae/glycyrrhiza = 1:1, aripiprazole <5 mg/day, and aripiprazole >10 mg/day were the most effective treatments in reducing the prolactin levels, respectively. Olanzapine 48-58 prolactin Homo sapiens 234-243 34421613-1 2021 The aim of the study was to assess the relationship between prolactin levels and sexual dysfunction in patients with schizophrenia who use olanzapine medication. Olanzapine 139-149 prolactin Homo sapiens 60-69 32318637-5 2020 Results: Olanzapine increased plasma prolactin, an effect that was reversed by co-administration of the D2 receptor agonist bromocriptine (P = .0002). Olanzapine 9-19 prolactin Homo sapiens 37-46 32695960-2 2020 Aims: This study aimed to explore the risk factors of elevated prolactin (PRL) caused by risperidone (RIS) and olanzapine (OLZ) and the relationship between PRL and fasting plasma glucose and lipids. Olanzapine 111-121 prolactin Homo sapiens 63-72 32695960-2 2020 Aims: This study aimed to explore the risk factors of elevated prolactin (PRL) caused by risperidone (RIS) and olanzapine (OLZ) and the relationship between PRL and fasting plasma glucose and lipids. Olanzapine 111-121 prolactin Homo sapiens 74-77 32695960-2 2020 Aims: This study aimed to explore the risk factors of elevated prolactin (PRL) caused by risperidone (RIS) and olanzapine (OLZ) and the relationship between PRL and fasting plasma glucose and lipids. Olanzapine 123-126 prolactin Homo sapiens 63-72 32695960-2 2020 Aims: This study aimed to explore the risk factors of elevated prolactin (PRL) caused by risperidone (RIS) and olanzapine (OLZ) and the relationship between PRL and fasting plasma glucose and lipids. Olanzapine 123-126 prolactin Homo sapiens 74-77 32695960-10 2020 In patients taking OLZ, the elevated PRL subgroup had lower fasting plasma glucose levels (U=2.29, p=0.022). Olanzapine 19-22 prolactin Homo sapiens 37-40 32695960-14 2020 The results also showed that high serum PRL may be associated with a favourable glucose metabolic profile in patients with schizophrenia taking RIS or OLZ. Olanzapine 151-154 prolactin Homo sapiens 40-43 30587989-0 2018 Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia. Olanzapine 13-23 prolactin Homo sapiens 33-42 30587989-2 2018 The existing evidences show that serum PRL is elevated in schizophrenic patients treated with olanzapine. Olanzapine 94-104 prolactin Homo sapiens 39-42 30587989-9 2018 Results: The olanzapine treatment for 12 weeks significantly increased serum PRL (P<0.01) level and BMI (P<0.01). Olanzapine 13-23 prolactin Homo sapiens 77-80 30587989-11 2018 Conclusion: Our findings suggest that PRL might conceivably modulate weight gain in female patients with schizophrenia receiving olanzapine treatment; however, the exact mechanism remains unclear. Olanzapine 129-139 prolactin Homo sapiens 38-41 31149301-9 2018 In case of the female patients, treatment with olanzapine (p=.021) and ziprasidone (p=.005) has been associated with a decrease of prolactin level in one year compared with baseline. Olanzapine 47-57 prolactin Homo sapiens 131-140 31149301-3 2018 Objective: The purpose of our study was to observe long-term (one year) prolactin level change in first episode schizophrenia patients treated with one of the four AAs: olanzapine, quetiapine, amisulpride, ziprasidone. Olanzapine 169-179 prolactin Homo sapiens 72-81 31149301-10 2018 Conclusions: In both men and women, the administration of these four AAs is not associated with the increase of prolactin levels, moreover, in women"s case, there is a reduction of prolactin values at administration of Olanzapine and Ziprasidone. Olanzapine 219-229 prolactin Homo sapiens 181-190 29802039-12 2018 Risperidone, haloperidol, paliperidone and olanzapine were associated with prolactin increase. Olanzapine 43-53 prolactin Homo sapiens 75-84 24052061-3 2013 This is the first report to measure serum prolactin levels in an olanzapine-overdosed toddler and the second to calculate olanzapine"s elimination half-life. Olanzapine 65-75 prolactin Homo sapiens 42-51 29805808-4 2018 Results: Five RCTs, including 989 patients combined, have evaluated the changes in prolactin for pediatric patients after 6 weeks of treatment with risperidone, quetiapine, aripiprazole, olanzapine, and paliperidone. Olanzapine 187-197 prolactin Homo sapiens 83-92 27825323-11 2016 In evidence gathered from randomized controlled trials, risperidone, olanzapine, and two doses of paliperidone (3-5 mg/day and 6-12 mg/day) were associated with increased prolactin levels compared to baseline. Olanzapine 69-79 prolactin Homo sapiens 171-180 26816428-0 2015 Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia. Olanzapine 82-92 prolactin Homo sapiens 50-59 26816428-13 2015 Prolactin level elevation was statistically significant in risperidone group followed by clozapine and olanzapine groups, respectively. Olanzapine 103-113 prolactin Homo sapiens 0-9 26508971-1 2015 In our previous study, a prolactin elevation was more frequently in risperidone than in blonanserin; however, it was more often in blonanserin than in olanzapine. Olanzapine 151-161 prolactin Homo sapiens 25-34 22447799-0 2012 Serum prolactin levels and the acute-phase efficacy in drug-naive schizophrenia treated with ziprasidone and olanzapine (translated version). Olanzapine 109-119 prolactin Homo sapiens 6-15 23375624-2 2013 We examined the differences in plasma PRL levels among 268 patients treated for schizophrenia with olanzapine (OLZ), risperidone (RIS), aripiprazole (ARP), quetiapine (QTP), or perospirone (PER). Olanzapine 99-109 prolactin Homo sapiens 38-41 23375624-2 2013 We examined the differences in plasma PRL levels among 268 patients treated for schizophrenia with olanzapine (OLZ), risperidone (RIS), aripiprazole (ARP), quetiapine (QTP), or perospirone (PER). Olanzapine 111-114 prolactin Homo sapiens 38-41 23131886-0 2012 Long-term effect of haloperidol, olanzapine, and risperidone on plasma prolactin levels in patients with first-episode psychosis. Olanzapine 33-43 prolactin Homo sapiens 71-80 23131886-1 2012 OBJECTIVE: The main goal of this study was to assess the long-term effect of haloperidol, olanzapine, and risperidone on serum prolactin levels in a naturalistically treated first-episode psychosis population. Olanzapine 90-100 prolactin Homo sapiens 127-136 23131886-5 2012 At 1-year follow-up, most patients in the haloperidol and olanzapine arms had prolactin values that fell within the reference range. Olanzapine 58-68 prolactin Homo sapiens 78-87 22447799-2 2012 To study the efficacy and associated serum prolactin levels of ziprasidone and olanzapine treatment in drug-naive schizophrenia patients. Olanzapine 79-89 prolactin Homo sapiens 43-52 22447799-11 2012 The increase of serum prolactin in the ziprasidone female group (47 +- 51 microg/L) was significantly higher than that in the ziprasidone male group (17 +- 11 microg/L), the olanzapine male group (5 +- 16 microg/L), and the olanzapine female group (21 +- 34 microg/L) [p < 0.05]. Olanzapine 174-184 prolactin Homo sapiens 22-31 22447799-11 2012 The increase of serum prolactin in the ziprasidone female group (47 +- 51 microg/L) was significantly higher than that in the ziprasidone male group (17 +- 11 microg/L), the olanzapine male group (5 +- 16 microg/L), and the olanzapine female group (21 +- 34 microg/L) [p < 0.05]. Olanzapine 224-234 prolactin Homo sapiens 22-31 21095016-0 2011 Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women. Olanzapine 71-81 prolactin Homo sapiens 49-58 22405602-8 2012 Quetiapine and ziprasidone display a better tolerability profile than risperidone and olanzapine in terms of weight gain, glucose metabolism, increases in prolactin levels, and EPS, while aripiprazole seems to be the most weight-neutral. Olanzapine 86-96 prolactin Homo sapiens 155-164 21869700-5 2011 Multiple regression analyses revealed that prolactin increases in maximum concentration and in area under the curve depended on drug (quetiapine < olanzapine < risperidone; P < 0.001), sex (women > men; P < 0.001), and Taq1A polymorphism (A1+ > A2/A2; P < 0.05). Olanzapine 150-160 prolactin Homo sapiens 43-52 21869700-6 2011 Analysis of the individual drugs revealed that prolactin secretion was modulated by sex and Taq1A polymorphism in olanzapine and risperidone (P < 0.05); however, these factors were not linked to prolactin secretion in quetiapine. Olanzapine 114-124 prolactin Homo sapiens 47-56 22351885-11 2012 Olanzapine caused more dyslipidemia and weight gain, but fewer prolactin-related events, than risperidone. Olanzapine 0-10 prolactin Homo sapiens 63-72 23090266-7 2012 Prolactin levels were higher in the patients treated with olanzapine compared with in those treated with clozapine at study start, but there were no differences in the other parameters between the treatment groups at study start. Olanzapine 58-68 prolactin Homo sapiens 0-9 21823168-0 2011 Dose-dependent effects of olanzapine on QT intervals and plasma prolactin levels in Japanese patients with stable schizophrenia. Olanzapine 26-36 prolactin Homo sapiens 64-73 21095016-2 2011 Single nucleotide polymorphisms (SNPs), rs2734842(C), rs6275(T), and rs6279(C) located within DRD2, have been shown to be associated with prolactin increase in olanzapine/fluoxetine combination (OFC)-treated women. Olanzapine 160-170 prolactin Homo sapiens 138-147 21095016-4 2011 An ANCOVA was used to test whether change from baseline in the natural log of prolactin concentration (ln[prolactin]) was associated with SNPs in the pooled olanzapine studies. Olanzapine 157-167 prolactin Homo sapiens 78-87 21095016-6 2011 Negative strand alleles rs2734842(C), rs6275(T), and rs6279(C) were significantly associated with increased prolactin in olanzapine-treated women, replicating previous results. Olanzapine 121-131 prolactin Homo sapiens 108-117 21095016-7 2011 These SNPs also showed moderate association with increased prolactin in olanzapine-treated and OFC-treated women in the meta-analysis, as did rs4938016, rs2734848, rs2734841, rs1124493, and rs1076562. Olanzapine 72-82 prolactin Homo sapiens 59-68